Teva-Loperamide · DIN 02132591 · 2 mg · Caplet
Limited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 required
Write on scriptone applicable Reason for Use code, 110 or 111 or 112 or 113 or 114 or 115 or 224 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 110, 111, 112, 113, 114, 115, 224
Coverage limit:
For the treatment of diarrhea associated with:
Reason for Use code 110
An ileostomy or a colostomy;.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 111
Bowel resection, including short bowel syndrome;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 112
Inflammatory Bowel Diseases, i.e. Crohn's Disease and Ulcerative Colitis;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 113
Cancer, including chemotherapy or radiation therapy;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 114
HIV/AIDS;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 115
Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 224
Fecal incontinence.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Teva-Loperamide · DIN 02132591
Manufacturer: Teva Canada Limited; listing date 1997-08-28
Health Canada: Marketed since 2016-12-23 · brand TEVA-LOPERAMIDE · ATC A07DA03 LOPERAMIDE · form Tablet · route Oral · ingredients LOPERAMIDE HYDROCHLORIDE 2 MG · company Teva canada limited · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Loperamide: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.0952). What the ministry pays, not the patient.
Ministry pays: $0.0952 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02132591)
Source record
DIN 02132591: Teva-Loperamide
Raw flags: sec12=Y, sec3=Y
Item: 560800015; group id 647; item number 1626; lccId 00096; manufacturer id TEV
Source form: Caplet; strength: 2mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.0952; ministry $0.0952
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02132591
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18071
Interchangeable products
Apo-Loperamide · DIN 02212005 · $0.0952
Imodium · DIN 00860743 · not recorded
PMS-Loperamide · DIN 02228351 · $0.0952
Shortage status: not checked (no credentials)